Anemia in Patients With Endocarditis (NCT04840225) | Clinical Trial Compass
CompletedNot Applicable
Anemia in Patients With Endocarditis
Denmark209 participantsStarted 2021-03-22
Plain-language summary
Prospective study of prevalence and deep charecterization of anemia in patients with endocarditis from diagnosis undtill 6 months after discharge.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
IE-patients:
Inclusion Criteria:
• Infectious endocarditis, defined by Duke criteria
Exclusion Criteria:
• Known rheumatic disease or immune defect
TAVI/TEVAR patients:
Inclusion Criteria:
• Scheduled for a TAVI/TEVAR procedure
Exclusion criteria:
* Clinical suspicion of infection
* Known rheumatic disease or immune defect
Bacterial patients without IE (short infection):
Inclusion criteria
* Patients admitted with an infection with gram positive bacteria, without IE Exclusion criteria
* Known rheumatic disease or immune defect
Blood donors:
Exclusion criteria:
* Antibiotic treatment within the last 2 months
* Cancer, rheumatic disease or other known inflammatory disease
* Surgery within the last 3 months
* Pregnancy
What they're measuring
1
Prevalence of anemia during hospitalization
Timeframe: From time of diagnosis/intervention untill end of follow-up (up to 6 months from inclusion)